Pune, India, Jan. 18, 2023 (GLOBE NEWSWIRE) -- The planetary nuclear medicine market size was valued astatine USD 5.04 cardinal successful 2020 and USD 5.57 cardinal successful 2021. The marketplace is expected to scope USD 19.47 by 2028 with a CAGR of 19.6% during the forecast period. The marketplace maturation is chiefly accredited to the rising occurrence of chronic conditions. Furthermore, technological progressions empowering the usage of radiopharmaceuticals to analyse and dainty cancerous tumors assistance towards marketplace growth.
Fortune Business Insights™ Share this accusation successful its study titled “Nuclear Medicine Market Forecast, 2023-2028.”
Industry Development
Bracco Diagnostics Inc. declared a collaboration with CardioNavix, LLC to heighten diligent entree to cardiac PET imaging. This caller program, the Bracco Mobile Isotope Service, volition empower much diligent attraction sites to supply cardiac PET imaging.
Request a Sample Copy of the Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2021 to 2028 |
| Forecast Period 2020 to 2027 CAGR | 19.6% |
| 2028 Value Projection | USD 19.47 Billion |
| Base Year | 2020 |
| Market Size successful 2020 | USD 5.04 Billion |
| Historical Data | 2017 to 2019 |
| No. of Pages | 169 |
Driving Factors
Technological Progressions successful Nuclear Imaging Modalities to Boost Market
One of the cardinal aspects for the atomic medicine marketplace maturation is the augmented consciousness concerning the imaginable power of superior and timely diagnosis and the corresponding affirmative sway successful the absorption and attraction of prolonged disorders. Developments successful atomic imaging technology, particularly PET/PET-CT, person helped successful the hold of applications of this modality beyond oncology to cardiology, neurology, and recognition of infections.
Key Takeaways
- The marketplace players who absorption connected a assortment of strategies, specified arsenic caller merchandise launches, are expected to summation revenues implicit the adjacent year.
- Developing caller therapeutic products for the attraction of antithetic aesculapian conditions, which stimulates the maturation of the market.
- North America generated USD 2.57billion successful 2020 and is expected to proceed to predominate the marketplace implicit the forecast period.
- The summation successful the prevalence of assorted cancers and different chronic conditions is expected to thrust marketplace maturation successful North America implicit the forecast period.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812
Segmentation
On the ground of the type, the marketplace is categorized into diagnostic and therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals conception is estimated to clasp the ascendant stock of the planetary marketplace successful 2020.
In presumption of application, the marketplace is classified into neurology, cardiology, oncology, and others.
By the end-user, the marketplace is divided into hospitals & clinics, diagnostic centers, and others.
Geographically, the marketplace is branched into North America, Europe, Asia Pacific, and the Rest of the World.
Regional Insights
North America to Lead Backed by Increased Usage of Therapeutic Radiopharmaceuticals
North America created a gross of USD 2.57 cardinal successful 2020 and is projected to proceed its dominance during the forecast period. The punctual adoption of operative atomic imaging technologies pooled with the rising utilization of technologically dependable and proficient therapeutic radiopharmaceuticals crossed the portion are anticipated to substance marketplace growth.
Europe is estimated to clasp the second-highest atomic medicine marketplace stock owed to the adoption of precocious radiopharmaceuticals and existent merchandise unveilings by salient players.
Asia Pacific is projected to grow astatine a important CAGR during the forecast period.
Competitive Landscape
Partnerships Commenced by Key Companies to Promote Market Growth
The dominating players successful the marketplace continually basal for resourceful strategies to promote their marque worth and besides beforehand the planetary marketplace maturation of the merchandise with facing slightest imaginable obstacles. One specified susceptible strategy is gaining competitory companies and truthful fortifying a nett for some the progressive companies.
Access Full Report - Nuclear Medicine Market: https://www.fortunebusinessinsights.com/checkout-page/101812
List of Key Players Covered successful the Report
- Lantheus Medical Imaging, Inc. (U.S.)
- Cardinal Health (U.S.)
- Norgine B.V. (Netherlands)
- Nordion (Canada) Inc. (Canada)
- Bayer AG (Germany)
- Curium (France)
- Advanced Accelerator Applications (Novartis AG) (France)
- Bracco Diagnostic Inc. (U.S.)
- Jubilant Pharmova Limited (India)
- GE Healthcare (General Electric Company) (U.S.)
Some large points from Table of Content:
- Introduction
- Market Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2019
- Installed Base of Gamma Cameras – For Key Countries, 2019
- PET/PET-CT Procedure Volume –for Key Countries, 2019
- Reimbursement Scenario- For Key Countries
- New Product Launches
- Key Industry Developments
- Pipeline Analysis
- Impact of COVID-19 connected the Market
- Global Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Diagnostics
- PET Radiopharmaceuticals
- FDG-PET/18F
- 68Ga
- 68Cu
- 11C
- Others
- SPECT Radiopharmaceuticals
- Technetium-99m
- Iodine-123
- Xenon-133
- Thallium-201
- Others
- PET Radiopharmaceuticals
- Therapeutics
- Diagnostics
- Market Analysis, Insights and Forecast – By Application
- Neurology
- Cardiology
- Oncology
- Others
- Market Analysis, Insights and Forecast – By End-user
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- North America Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Diagnostics
- PET Radiopharmaceuticals
- FDG-PET/18F
- 68Ga
- 68Cu
- 11C
- Others
- SPECT Radiopharmaceuticals
- Technetium-99m
- Iodine-123
- Xenon-133
- Thallium-201
- Others
- PET Radiopharmaceuticals
- Therapeutics
- Diagnostics
- Market Analysis, Insights and Forecast – By Application
- Neurology
- Cardiology
- Oncology
- Others
- Market Analysis, Insights and Forecast – By End-user
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Europe Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Diagnostics
- PET Radiopharmaceuticals
- FDG-PET/18F
- 68Ga
- 68Cu
- 11C
- Others
- SPECT Radiopharmaceuticals
- Technetium-99m
- Iodine-123
- Xenon-133
- Thallium-201
- Others
- PET Radiopharmaceuticals
- Therapeutics
- Diagnostics
TOC Continued….
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812
Related Links:
Radiation Dose Management Market Size, Share, Revenue Forecast and Opportunities
Radiation Therapy Market Overview, Industry Share and Forecast
Digital Radiography Market Size, Share, Opportunities & Analysis
About Us:
Fortune Business Insights™ offers adept firm investigation and close data, helping organizations of each sizes marque timely decisions. We tailor innovative solutions for our clients, assisting them code challenges chiseled to their businesses. Our extremity is to empower our clients with holistic marketplace intelligence, giving a granular overview of the marketplace they are operating in. Our reports incorporate a unsocial premix of tangible insights and qualitative investigation to assistance companies execute sustainable growth. Our squad of experienced analysts and consultants usage industry-leading probe tools and techniques to compile broad marketplace studies, interspersed with applicable data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
English (US)